Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers.
about
Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapyTicagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An UpdateSevere Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor.Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety.Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.Drug-drug interactions that interfere with statin metabolism.Commentary: Should Pharmacogenomic Evidence Be Considered in Clinical Decision Making? Focus on Select Cardiovascular Drugs.Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy?Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers.Pharmacokinetics and pharmacodynamics of ticagrelor when treating non-ST elevation acute coronary syndromes.Ticagrelor-induced life-threatening bleeding via the cyclosporine-mediated drug interaction: A case report.Ticagrelor Leads to Statin-Induced Rhabdomyolysis: A Case Report.Statin drug interactions and related adverse reactions: an update.Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy.Ticagrelor - toward more efficient platelet inhibition and beyond.Ticagrelor: A Review in Long Term Secondary Prevention of Cardiovascular Events.Elevated Creatine Kinase due to Potential Drug Interaction With Ticagrelor and Atorvastatin.
P2860
Q26852535-77E0C22E-4D86-4B7B-A474-2127C52224CFQ27006031-FBDF96F5-06FF-46BF-A8DE-B90B127818F1Q33775454-8A3E980C-9DC7-43FF-BA90-ADCBAD30933CQ34680467-AB8080B0-BCF3-47C6-95F2-A5C5F73AEA73Q34805121-DB398ED2-F31D-4FF1-86EA-9A98C6585B49Q37414997-4494CFAD-7087-4845-86AC-0D7DD76F6A62Q38522299-1B368A37-FFB4-4135-8112-E7F0E95904A7Q38707185-7ECA53DD-E1D2-4658-8EF5-F3A094F3138CQ38780360-C05083E2-5FA5-4A9B-9D1F-48110EA42CC3Q38974884-8A0E1C5E-4D2A-466B-9FA4-1398AF5D760AQ39478831-F930C233-9A8C-4A92-A709-EBDBE7B9ACD6Q41060485-54E277E7-AB87-4F6C-8285-94B9F6B87646Q42360790-82C86B6D-6D9B-469F-A3C3-0CBD5735B0F3Q47147015-A5386D85-89E8-4AF8-9C56-A7D83602A72EQ48145497-BA7309FD-55C7-47BA-8519-1D463DC6604FQ48344587-6F03D650-6292-42C8-8281-577B299811FAQ49337303-838E7225-3894-4EA1-A6FC-D7DCB12D7BF2Q49908641-E07D4E49-2201-4EB4-87E5-9C6B7E0B4E7BQ52819323-1393B1E1-CB48-4A63-BEE3-153A4CE8DEE0
P2860
Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Pharmacokinetic interaction st ...... astatin in healthy volunteers.
@en
Pharmacokinetic interaction st ...... astatin in healthy volunteers.
@nl
type
label
Pharmacokinetic interaction st ...... astatin in healthy volunteers.
@en
Pharmacokinetic interaction st ...... astatin in healthy volunteers.
@nl
prefLabel
Pharmacokinetic interaction st ...... astatin in healthy volunteers.
@en
Pharmacokinetic interaction st ...... astatin in healthy volunteers.
@nl
P2093
P2860
P1476
Pharmacokinetic interaction st ...... astatin in healthy volunteers.
@en
P2093
Kathleen A Butler
Patrick D Mitchell
Renli Teng
P2860
P2888
P304
P356
10.1007/S00228-012-1369-4
P577
2012-08-25T00:00:00Z